Recent studies have shown that about 40% patients with FBH [34], 10% of familial FSGS patients [35], and <5% AS patients carry heterozygous mutations in COL4A3 or COL4A4 [18]. Here, COL4A3 is linked to focal segmental glomerulosclerosis.